With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry. Why is Big Pharma suddenly placing bets—big and small—on a medicine ...

Magnificent Seven stocks. Big Tech's runaway growth created gains, but headwinds are forming and some observers doubt the Mag ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

"I'm really excited to see how we're going to be able to use that money to impact families in Baltimore City positively," ...

RFK Jr.'s call to ban TV advertisements for prescription drugs reignited support for a bipartisan bill that would mandate the retail prices of drugs be included in TV ads.

Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the ...

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies.

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...